While government funding cannot solve many of the challenges faced by the pharmaceutical industry in the UK, the country’s drugs regulator does need more funding to rebuild itself in a post-Brexit context, according to venture capitalist Dame Kate Bingham.
The MHRA “has lost vast amounts of industry funding because companies no longer want to come to the UK to...







